New “Compromise” on an IP Waiver for Covid Vaccines Is Worse Than No Deal, Activists Say

“Even if vaccines were the only consideration, overriding patents alone is not enough,” Professor Brook Baker, senior policy analyst for Health GAP, tells In These Times magazine.